Tata Capital anticipates strong performance in FY27, driven by growth, improved margins, and operating efficiency. The company has seen a consistent decline in credit costs, a trend expected to continue due to a disciplined risk culture and the adoption of AI. Loan book growth is projected to be robust, with a focus on housing finance and retail products.
The Indian rupee declined in all five trading sessions to log its steepest week-on-week loss since September 2022, as worries over the fragility of a U.S.-Iran ceasefire and disrupted energy flows sparked a renewed surge in oil prices.
SBI Funds Management Ltd. is preparing to launch its initial public offering as early as next week, aiming to raise up to $1.5 billion. The Indian asset manager plans to allocate roughly three-quarters of the issue to domestic investors and is exploring a pre-IPO placement of up to $350 million.
Indian markets present attractive long-term investment opportunities following recent corrections, according to Nitin Raheja of Julius Baer. He advises staggered investing, highlighting power and energy, PSU banks, insurance, and defence as key sectors. While near-term volatility persists, Raheja believes the earnings outlook remains robust, with potential for a shift into the next financial year.
US mortgage rates fell for a third straight week, with the 30-year fixed rate easing to 6.23%, its lowest since mid-March. Declining Treasury yields supported the trend, though volatility from inflation and geopolitical risks persists. Despite easing borrowing costs, housing activity remains subdued amid affordability and demand pressures.
Axis Bank is expected to report a mixed Q4FY26 performance with muted year-on-year profit growth despite steady loan and deposit expansion. Margins are likely to remain under pressure due to rate transmission, while sequential trends improve. Asset quality and credit costs will remain key monitorables for investors.
JPMorgan downgraded Indian equities to Neutral from Overweight, warning the Nifty could fall to 20,500 in a bear-case scenario, implying a 15% downside. While the long-term outlook remains intact, near-term risks such as elevated valuations, Iran war uncertainty and energy disruptions persist. The brokerage flagged earnings risks, with analysts cutting FY27 estimates and trimming MSCI India EPS growth forecasts.
Dr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation risks. Brokerages flagged lower earnings potential amid generics pricing pressure and muted opportunities in semaglutide. Despite earlier optimism, analysts see downside risks persisting in the near term.
Japan’s core inflation slipped below the Bank of Japan’s 2% target for a second straight month in March, as subsidies and easing food prices offset energy pressures. While underlying inflation remains resilient, rising oil costs and geopolitical risks may push prices higher, keeping policymakers cautious on future interest rate decisions.
HCL Tech shares have plunged sharply after weak Q4 earnings and subdued FY27 guidance, triggering multiple broker downgrades and target cuts. Concerns over slowing growth, reduced discretionary spending, and limited visibility on recovery have weighed on sentiment, with analysts expecting continued pressure on the stock in the near term.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.